Agenix Limited - ADR (AGXLY) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Agenix Limited - ADR Company Snapshot

Business Description:

Agenix Limited - ADR operates in the Commercial physical research sector. Agenix Limited is engaged in the development of ThromboView project, a product in development related to the detection of blood clots. Its lead product, ThromboView, is an internally developed, humanised monoclonal antibody based imaging technology that detects live blood clots in the human body. The Company's lead indicator, ThromboView uses radiolabelled antibodies, which bind to a biomarker to locate active blood clots in the body. It also engaged in the development of the operations of Shanghai Rui Guang Bio-Pharma Development Co Limited (SHRG) in respect of expanding a pipeline of anti-viral drugs for international distribution. The Company operates in three segments: Agenix (Shanghai) Biopharmaceuticals, Monoclonal antibody product development and Molecular biology.

Stock Performance Chart for Agenix Limited - ADR

Stock Data:

Recent Stock Performance:

Current Price (11/12/2010): 1.19
(Figures in U.S. Dollars)

1 Week	n/a	13 Weeks	n/a

4 Weeks	n/a	52 Weeks	n/a

Agenix Limited - ADR Key Data:

Ticker:	AGXLY	Country:	AUSTRALIA

Exchanges:	JAK	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	5,455 (Year Ending Jan 2011).	Employees:	4

Currency:	U.S. Dollars	Market Cap:	17,731,189

Fiscal Yr Ends:	June	Shares Outstanding:	14,946,632

Share Type:	Ordinary	Closely Held Shares:	5,095,782

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.